These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29510967)

  • 1. Treatment with growth hormone in the prader-willi syndrome.
    Moix Gil E; Giménez-Palop O; Caixàs A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Apr; 65(4):229-236. PubMed ID: 29510967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.
    Jin YY; Luo FH
    Eur J Pediatr; 2024 Mar; 183(3):1021-1036. PubMed ID: 37987848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
    Grugni G; Marzullo P
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time for a general approval of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C; Holland AJ; Driscoll DJ;
    Orphanet J Rare Dis; 2021 Feb; 16(1):69. PubMed ID: 33557878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone treatment in a girl with Prader Willi syndrome.
    Pandey SN; Vaidya RA; Irani A
    Indian J Pediatr; 2003 Apr; 70(4):351-3. PubMed ID: 12793314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment for Prader-Willi syndrome: A review.
    Yang X
    Neuropeptides; 2020 Oct; 83():102084. PubMed ID: 32859387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
    Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
    Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome.
    Shukur HH; Hussain-Alkhateeb L; Farholt S; Nørregaard O; Jørgensen AP; Hoybye C
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3634-e3643. PubMed ID: 33950234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatropin therapy in adults with Prader-Willi syndrome.
    Höybye C; Thorén M
    Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
    Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
    J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Hormone Treatment for Prader-Willi Syndrome.
    Tauber M; Diene G; Molinas C
    Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):91-99. PubMed ID: 30378786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effect of Growth Hormone Treatment on Health-Related Quality of Life in Children with Prader-Willi Syndrome: A Randomized Controlled Trial and Longitudinal Study.
    Bakker NE; Siemensma EP; van Rijn M; Festen DA; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 84(4):231-9. PubMed ID: 26279206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prader-Willi syndrome. Treatment with growth hormone in 2 cases].
    Youlton R
    Rev Med Chil; 2001 Oct; 129(10):1186-90. PubMed ID: 11775347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
    Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
    J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.